Content about Low-density lipoprotein

May 17, 2013

Mylan has launched a generic drug for treating cholesterol, the company said.

PITTSBURGH — Mylan has launched a generic drug for treating cholesterol, the company said Friday.

Mylan announced the launch of fenofibrate tablets in the 48 mg and 145 mg strengths. The drug is used to reduce so-called "bad" low-density lipoprotein cholesterol, total cholesterol, triglycerides and apolipoprotein B while increasing "good" high-density lipoprotein cholesterol in adults with primary hyperocholesterolemia or mixed dyslipidemia.

May 6, 2013

The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has approved a new drug made by Merck for treating high cholesterol, the drug maker said.

Merck announced the approval of Liptruzet (ezetimibe and atorvastatin). The drug combines two preexisting cholesterol drugs: ezetimibe, which Merck markets under the brand name Zetia, and atorvastatin, which Pfizer markets under the name Lipitor. Both drugs are available as generics, but because Liptruzet is a novel combination of them, it required FDA approval as a new drug.

March 22, 2013

Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.

MOUNTAIN VIEW, Calif. — Culturally competent coaching may be effective in reducing the risk of coronary artery disease among South Asian patients, according to a new study presented as a poster at an American Heart Association conference taking place in New Orleans.

March 14, 2013

Walgreens was singled out in a lawsuit earlier this week for suggesting a vitamin E supplement may help improve cardiovascular health.

BAKERSFIELD, Calif. — Walgreens was singled out in a lawsuit earlier this week here for suggesting a vitamin E supplement may help improve cardiovascular health. 

Specifically, according to a Reuters report Monday, the complainant stated that Walgreens' Vitamin E 400 IU purported to "naturally contribute to cardiovascular health by helping to protect LDL cholesterol from oxidation which may cause cellular damage." 

January 30, 2013

The Food and Drug Administration has approved a new drug for treating a rare cholesterol disorder, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating a rare cholesterol disorder, the agency said.

The FDA announced the approval of Kynamro (mipomersen sodium), made by Genzyme for the treatment of homozygous familial hypercholesterolemia, or HoFH. Kynamro has been approved as an orphan drug, a designation the FDA gives to drugs that treat diseases affecting fewer than 200,000 people.

October 18, 2012

An uptick in the use of cholesterol drugs since the late 1980s and changes in Americans' diets may account for a fall in cholesterol levels, according to a new study by the Centers for Disease Control and Prevention.

NEW YORK — An uptick in the use of cholesterol drugs since the late 1980s and changes in Americans' diets may account for a fall in cholesterol levels, according to a new study by the Centers for Disease Control and Prevention.

August 13, 2012

In a study involving more than 16,000 U.S. children and adolescents, there has been a decrease in average total cholesterol levels over the past two decades, although almost 1-in-10 subjects had elevated total cholesterol in the 2007-2010 period, according to a study published in the Aug. 8 issue of the Journal of the American Medical Association.

CHICAGO — In a study involving more than 16,000 U.S. children and adolescents, there has been a decrease in average total cholesterol levels over the past two decades, although almost 1-in-10 subjects had elevated total cholesterol in the 2007-2010 period, according to a study published in the Aug. 8 issue of the Journal of the American Medical Association.

May 22, 2012

Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

NEW YORK — Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

March 12, 2012

The news that Walgreens outlined how face-to-face pharmacy and Take Care Clinic programs have been shown to drive better health outcomes further illustrates the fact that human interaction simply does things that mail order cannot.

WHAT IT MEANS AND WHY IT'S IMPORTANT — The news that Walgreens outlined how face-to-face pharmacy and Take Care Clinic programs have been shown to drive better health outcomes further illustrates the fact that human interaction simply does things that mail order cannot.

February 16, 2012

A study published in the November 2011 International Journal of Food Sciences and Nutrition demonstrated a nearly 5% reduction in “bad” low-density lipoprotein cholesterol when Pharmavite's CholestOff was added to the National Cholesterol Education Program therapeutic lifestyle changes diet, Pharmavite announced Wednesday.

NORTHRIDGE, Calif. — A study published in the November 2011 International Journal of Food Sciences and Nutrition demonstrated a nearly 5% reduction in “bad” low-density lipoprotein cholesterol when Pharmavite's CholestOff was added to the National Cholesterol Education Program therapeutic lifestyle changes diet, Pharmavite announced Wednesday.

July 6, 2011

Consuming nuts in place of carbohydrates may help improve long-term blood-sugar control and lower cholesterol levels among Type 2 diabetics, according to a new study.

FRESNO, Calif. — Consuming nuts in place of carbohydrates may help improve long-term blood-sugar control and lower cholesterol levels among Type 2 diabetics, according to a new study.

December 15, 2010

A recent scientific study showed that incorporating almonds into a person’s diet can help treat and possibly prevent Type 2 diabetes, as well as cardiovascular disease, the Almond Board of California announced Wednesday.

MODESTO, Calif. — A recent scientific study showed that incorporating almonds into a person’s diet can help treat and possibly prevent Type 2 diabetes, as well as cardiovascular disease, the Almond Board of California announced Wednesday.

The study, published in the June 2010 Journal of the American College of Nutrition illustrated that consuming a diet rich in almonds may help improve insulin sensitivity and decrease LDL-cholesterol levels in those with pre-diabetes.

November 16, 2010

Patients taking an investigational treatment for cardiovascular disease showed big improvements in cholesterol levels, according...

WHITEHOUSE STATION, N.J. Patients taking an investigational treatment for cardiovascular disease showed big improvements in cholesterol levels, according to late-stage clinical trial results released Wednesday.

 

August 18, 2010

UnitedHealthcare and Affiliated Associations of America on Thursday announced that complimentary at-home health screening kits...

MERCER ISLAND, Wash. UnitedHealthcare and Affiliated Associations of America on Thursday announced that complimentary at-home health screening kits now are available to the approximate 9,000 AAOA employees and their families.

The kits, developed by Santa Barbara, Calif.-based BioIQ, enable individuals to more easily test for such conditions as diabetes and heart disease, and help patients work with their doctors to more quickly develop appropriate treatment plans.

 

August 5, 2010

Biotech company Genzyme and Isis Pharmaceuticals have finished late-stage clinical trials of a cholesterol-lowering drug,...

June 20, 2010

A new cholesterol drug made by Eli Lilly and Kowa Pharmaceuticals America has become available,...

May 10, 2010

A pooled analysis of 25 trials found that nut consumption may improve blood cholesterol levels....

March 7, 2010

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to...

February 9, 2010

A drug for treating a genetic cholesterol disorder decreased levels of “bad” LDL cholesterol in...